Hasil Pencarian - Nathan Cantoni
- Menampilkan 1 - 8 hasil dari 8
-
1
-
2
Real-world impact of primary immune thrombocytopenia and treatment with thrombopoietin receptor agonists on quality of life based on patient-reported experience: Results from a que... oleh Alicia Rovó, Nathan Cantoni, Kaveh Samii, Axel Rüfer, Giedre Koenen, Sandra Ivic, Davide Cavanna, Rudolf Benz
Diterbitkan 2022-01-01
Artikel -
3
Real-world impact of primary immune thrombocytopenia and treatment with thrombopoietin receptor agonists on quality of life based on patient-reported experience: Results from a que... oleh Alicia Rovó, Nathan Cantoni, Kaveh Samii, Axel Rüfer, Giedre Koenen, Sandra Ivic, Davide Cavanna, Rudolf Benz
Diterbitkan 2022-01-01
Artikel -
4
A multicenter real-world evidence study in the Swiss treatment landscape of chronic myeloid leukemia oleh Nathan Cantoni, Roberto Sommavilla, Patrick Seitz, Elisabeth Kulenkampff, Stefan Kahn, Jean-François Lambert, Adrian Schmidt, Reinhard Zenhaeusern, Stefan Balabanov
Diterbitkan 2022-11-01
Artikel -
5
-
6
Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia oleh Franziska C. Adam, Jakub Szybinski, Jörg P. Halter, Nathan Cantoni, Friedel Wenzel, Katharina Leonards, Sime Brkic, Jakob R. Passweg, Ivo Touw, Julia E. Maxson, Sara C. Meyer
Diterbitkan 2022-02-01
Artikel -
7
The sympathomimetic agonist mirabegron did not lower JAK2-V617F allele burden, but restored nestin-positive cells and reduced reticulin fibrosis in patients with myeloproliferative... oleh Beatrice Drexler, Jakob R. Passweg, Alexandar Tzankov, Martin Bigler, Alexandre PA Theocharides, Nathan Cantoni, Peter Keller, Georg Stussi, Axel Ruefer, Rudolf Benz, Geneviève Favre, Pontus Lundberg, Ronny Nienhold, Andrea Fuhrer, Christine Biaggi, Markus G. Manz, Mario Bargetzi, Simon Mendez-Ferrer, Radek C. Skoda
Diterbitkan 2019-04-01
Artikel -
8
Real-world Data From the Swiss Lenalidomide in MDS del(5q) (SLIM)—Registry Identify New Chances and Challenges in Lenalidomide Treatment of Patients With MDS del(5q) oleh Axel Rüfer, Hubert Angermann, Rudolf Benz, Nicolas Bonadies, Antonello Calderoni, Nathan Cantoni, Anna Efthymiou, Robert Escher, Geneviève Favre, Dorothea Friess, Andreas Gschwend, Andreas Himmelmann, Andreas Holbro, Peter Keller, Eirini Kouroupi, Thomas Lehmann, Nikolaus Pedarnig, Véronique Rigamonti, Kaveh Samii, Adrian Schmidt, Hans-Peter Schäfer, Roland Sperb, Georg Stüssi, Annette Winkler, Reinhard Zenhäusern, Jeroen S. Goede, on behalf of the SLIM-Registry Investigators*
Diterbitkan 2022-07-01
Artikel